Efficacy and safety of the combination of metformin, everolimus and exemestane in overweight and obese postmenopausal patients with metastatic, hormone receptor-positive, HER2-negative breast cancer: a phase II study

Clinton Yam, Francisco J. Esteva, Miral M. Patel, Akshara S. Raghavendra, Naoto T. Ueno, Stacy L. Moulder, Kenneth R. Hess, Girish S. Shroff, Silvia Hodge, Kimberly H. Koenig, Mariana Chavez Mac Gregor, Robin L. Griner, Sai Ching J. Yeung, Gabriel N. Hortobagyi, Vicente Valero

Research output: Contribution to journal › Article › peer-review

29 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and safety of the combination of metformin, everolimus and exemestane in overweight and obese postmenopausal patients with metastatic, hormone receptor-positive, HER2-negative breast cancer: a phase II study'. Together they form a unique fingerprint.

Medicine & Life Sciences